Capital Advisors »

Cytek Biosciences shares owned by Capital Advisors

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Capital Advisors from 13F filings

Historical chart of Capital Advisors investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $0 39 0.00
2023-12-31 $0 39 0.00

More positions owned by Capital Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus 1000 Grw Etf (IWF)
Caesars Entertainment (CZR)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Ishares Tr Rus 1000 Val Etf (IWD)
Ishares Tr Msci Usa Min Vol (USMV)
Ishares Tr S&p Mc 400gr Etf (IJK)
Spdr Ser Tr S&p Divid Etf (SDY)
Vanguard Index Fds Total Stk Mkt (VTI)
Ishares Tr Core Div Grwth (DGRO)
Ishares Tr S&p Mc 400vl Etf (IJJ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Invesco Exch Traded Fd Tr Ii S&p500 Low Vol (SPLV)
Ishares Tr S&p 500 Grwt Etf (IVW)

View all positions for Capital Advisors

Top funds holding Cytek Biosciences

Vanguard Group
RA Capital Management
Hillhouse Capital Advisors
New York State Common Retirement Fund
Wellington Management Company
Dimensional Fund Advisors
Charles Schwab Investment Management
Bank of New York Mellon
Goldman Sachs Group
Connor, Clark & Lunn Investment Management
Principal Financial Group
Rhumbline Advisers
Legal & General Group
State of Wisconsin Investment Board
Swiss National Bank

View all funds holding Cytek Biosciences